Literature DB >> 15654872

Physicochemical characterization of carboxymethyl lipid A derivatives in relation to biological activity.

Ulrich Seydel1, Andra B Schromm, Lore Brade, Sabine Gronow, Jörg Andrä, Mareike Müller, Michel H J Koch, Koichi Fukase, Mikayo Kataoka, Masaya Hashimoto, Shoichi Kusumoto, Klaus Brandenburg.   

Abstract

Lipopolysaccharide (LPS) from the outer membrane of Gram-negative bacteria belongs to the most potent activators of the mammalian immune system. Its lipid moiety, lipid A, the 'endotoxic principle' of LPS, carries two negatively charged phosphate groups and six acyl chain residues in a defined asymmetric distribution (corresponding to synthetic compound 506). Tetraacyl lipid A (precursor IVa or synthetic 406), which lacks the two hydroxylated acyl chains, is agonistically completely inactive, but is a strong antagonist to bioactive LPS when administered to the cells before LPS addition. The two negative charges of lipid A, represented by the two phosphate groups, are essential for agonistic as well as for antagonistic activity and no highly active lipid A are known with negative charges other than phosphate groups. We hypothesized that the phosphate groups could be substituted by other negatively charged groups without changing the endotoxic properties of lipid A. To test this hypothesis, we synthesized carboxymethyl (CM) derivatives of hexaacyl lipid A (CM-506 and Bis-CM-506) and of tetraacyl lipid A (Bis-CM-406) and correlated their physicochemical with their endotoxic properties. We found that, similarly to compounds 506 and 406, also for their carboxymethyl derivatives a particular molecular ('endotoxic') conformation and with that, a particular aggregate structure is a prerequisite for high cytokine-inducing capacity and antagonistic activity, respectively. In other parameters such as acyl chain melting behaviour, antibody binding, activity in the Limulus lysate assay, and partially the binding of 3-deoxy-D-manno-oct-2-ulosonic acid transferase, strong deviations from the properties of the phosphorylated compounds were observed. These data allow a better understanding of endotoxic activity and its structural prerequisites.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15654872     DOI: 10.1111/j.1742-4658.2004.04471.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  5 in total

1.  The native 67-kilodalton minor fimbria of Porphyromonas gingivalis is a novel glycoprotein with DC-SIGN-targeting motifs.

Authors:  Amir E Zeituni; William McCaig; Elizabeth Scisci; David G Thanassi; Christopher W Cutler
Journal:  J Bacteriol       Date:  2010-06-18       Impact factor: 3.490

2.  Interaction of the HIV-1 gp120 viral protein V3 loop with bacterial lipopolysaccharide: a pattern recognition inhibition.

Authors:  Andreja Majerle; Primoz Pristovsek; Mateja Mancek-Keber; Roman Jerala
Journal:  J Biol Chem       Date:  2011-06-02       Impact factor: 5.157

3.  Characterization of a Novel d-Glycero-d-talo-oct-2-ulosonic acid-substituted Lipid A Moiety in the Lipopolysaccharide Produced by the Acetic Acid Bacterium Acetobacter pasteurianus NBRC 3283.

Authors:  Masahito Hashimoto; Mami Ozono; Maiko Furuyashiki; Risako Baba; Shuhei Hashiguchi; Yasuo Suda; Koichi Fukase; Yukari Fujimoto
Journal:  J Biol Chem       Date:  2016-08-18       Impact factor: 5.157

4.  WaaA of the hyperthermophilic bacterium Aquifex aeolicus is a monofunctional 3-deoxy-D-manno-oct-2-ulosonic acid transferase involved in lipopolysaccharide biosynthesis.

Authors:  Uwe Mamat; Helgo Schmidt; Eva Munoz; Buko Lindner; Koichi Fukase; Anna Hanuszkiewicz; Jing Wu; Timothy C Meredith; Ronald W Woodard; Rolf Hilgenfeld; Jeroen R Mesters; Otto Holst
Journal:  J Biol Chem       Date:  2009-06-22       Impact factor: 5.157

5.  The synthetic glycolipid-based TLR4 antagonist FP7 negatively regulates in vitro and in vivo haematopoietic and non-haematopoietic vascular TLR4 signalling.

Authors:  Charys Palmer; Francesco Peri; Frank Neumann; Feroz Ahmad; David S Leake; Grisha Pirianov
Journal:  Innate Immun       Date:  2018-09-12       Impact factor: 2.680

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.